TP53 and hepatocellular carcinoma: Moreover, the study by Lee and Kwon, 2019, also revealed other significant findings, such as that Luteolin was able to induce apoptosis and inhibit cell proliferation in only p53-null Hep3B cells, not in the p53-wild type HepG2 hepatocellular carcinoma cells.